{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:41:44Z","timestamp":1790422904494,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Project supported by the Health Research Program of Anhui","award":["AHWJ2023A10059"],"award-info":[{"award-number":["AHWJ2023A10059"]}]},{"name":"Research Projects of Higher Education Institutions in Anhui Province","award":["2024AH040189"],"award-info":[{"award-number":["2024AH040189"]}]},{"name":"Research Projects of Higher Education Institutions in Anhui Province","award":["2024AH051270"],"award-info":[{"award-number":["2024AH051270"]}]},{"name":"Project supported by the Health Research Program of BengBu","award":["BBWK2024B203"],"award-info":[{"award-number":["BBWK2024B203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01300-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:29:38Z","timestamp":1759220978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["METTL14 knockdown augmented the polarization of M2-like macrophages to promote acute myeloid leukemia progression"],"prefix":"10.1007","volume":"38","author":[{"given":"Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1300_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.semcancer.2020.11.010","volume":"83","author":"X Zhao","year":"2022","unstructured":"Zhao X, Liu HQ, Wang LN, Yang L, Liu XL. Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities. Semin Cancer Biol. 2022;83:121\u201335. https:\/\/doi.org\/10.1016\/j.semcancer.2020.11.010.","journal-title":"Semin Cancer Biol"},{"issue":"5s","key":"1300_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.6004\/jnccn.2018.0050","volume":"16","author":"M Tallman","year":"2018","unstructured":"Tallman M. Prognostic significance of molecular markers and targeted regimens in the management of acute myeloid leukemia. J Natl Compr Cancer Netw JNCCN. 2018;16(5s):656\u20139. https:\/\/doi.org\/10.6004\/jnccn.2018.0050.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"5","key":"1300_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11899-016-0339-9","volume":"11","author":"HF Fernandez","year":"2016","unstructured":"Fernandez HF. What is the optimal induction therapy for younger fit patients with AML? Curr Hematol Malig Rep. 2016;11(5):327\u201332. https:\/\/doi.org\/10.1007\/s11899-016-0339-9.","journal-title":"Curr Hematol Malig Rep"},{"issue":"6","key":"1300_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00432-021-03733-0","volume":"148","author":"M Fleischmann","year":"2022","unstructured":"Fleischmann M, Schnetzke U, Frietsch JJ, et al. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia. J Cancer Res Clin Oncol. 2022;148(6):1481\u201392. https:\/\/doi.org\/10.1007\/s00432-021-03733-0.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1300_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-022-01231-5","volume":"15","author":"Q Guan","year":"2022","unstructured":"Guan Q, Lin H, Miao L, et al. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer. J Hematol Oncol. 2022;15(1):13. https:\/\/doi.org\/10.1186\/s13045-022-01231-5.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"1300_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell. 2018;22(2):191-205.e9. https:\/\/doi.org\/10.1016\/j.stem.2017.11.016.","journal-title":"Cell Stem Cell"},{"issue":"22","key":"1300_CR7","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1182\/blood.V128.22.1536.1536","volume":"128","author":"H Huang","year":"2016","unstructured":"Huang H, Weng H, Qin X, et al. The N6-adenine methyltransferase METTL14 plays an oncogenic role in acute myeloid leukemia. Blood. 2016;128(22):1536. https:\/\/doi.org\/10.1182\/blood.V128.22.1536.1536.","journal-title":"Blood"},{"issue":"12","key":"1300_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900327","volume":"6","author":"H Qin","year":"2019","unstructured":"Qin H, Yu H, Sheng J, et al. PI3Kgamma inhibitor attenuates immunosuppressive effect of poly(l-glutamic acid)-combretastatin A4 conjugate in metastatic breast cancer. Adv Sci. 2019;6(12):1900327. https:\/\/doi.org\/10.1002\/advs.201900327.","journal-title":"Adv Sci"},{"issue":"7","key":"1300_CR9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41423-019-0235-z","volume":"17","author":"SJ Kim","year":"2020","unstructured":"Kim SJ, Chang HJ, Volin MV, et al. Macrophages are the primary effector cells in IL-7-induced arthritis. Cell Mol Immunol. 2020;17(7):728\u201340. https:\/\/doi.org\/10.1038\/s41423-019-0235-z.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1300_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12(1):76. https:\/\/doi.org\/10.1186\/s13045-019-0760-3.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"1300_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.4049\/jimmunol.2300339","volume":"212","author":"B Wang","year":"2024","unstructured":"Wang B, Mao Z, Ye J, et al. Glycolysis induced by METTL14 is essential for macrophage phagocytosis and phenotype in cervical cancer. J Immunol. 2024;212(4):723\u201336. https:\/\/doi.org\/10.4049\/jimmunol.2300339.","journal-title":"J Immunol"},{"key":"1300_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106253","volume":"185","author":"Y Li","year":"2023","unstructured":"Li Y, Li J, Yu Q, Ji L, Peng B. METTL14 regulates microglia\/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis. Neurobiol Dis. 2023;185:106253. https:\/\/doi.org\/10.1016\/j.nbd.2023.106253.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1300_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04331-0","volume":"79","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Li Y, Ran X, et al. Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-\u03baB\/IL-6 signaling pathway. Cell Mol Life Sci. 2022;79(6):311. https:\/\/doi.org\/10.1007\/s00018-022-04331-0.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1300_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0421-3","volume":"10","author":"YJ Huang","year":"2017","unstructured":"Huang YJ, Yang CK, Wei PL, et al. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J Hematol Oncol. 2017;10(1):60. https:\/\/doi.org\/10.1186\/s13045-017-0421-3.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1300_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23(1):37\u201345. https:\/\/doi.org\/10.1016\/j.intimp.2014.08.002.","journal-title":"Int Immunopharmacol"},{"key":"1300_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2017.05.027","volume":"88","author":"H Shiratori","year":"2017","unstructured":"Shiratori H, Feinweber C, Luckhardt S, et al. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro. Mol Immunol. 2017;88:58\u201368. https:\/\/doi.org\/10.1016\/j.molimm.2017.05.027.","journal-title":"Mol Immunol"},{"issue":"1","key":"1300_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010.","journal-title":"Immunity"},{"issue":"2","key":"1300_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113587","volume":"427","author":"X Yang","year":"2023","unstructured":"Yang X, Wang C, Zhu G, Guo Z, Fan L. METTL14\/YTHDF1 axis-modified UCHL5 aggravates atherosclerosis by activating the NLRP3 inflammasome. Exp Cell Res. 2023;427(2):113587. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113587.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1300_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01797-1","volume":"9","author":"YF Wang","year":"2024","unstructured":"Wang YF, Zhang WL, Li ZX, et al. Mettl14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression. Signal Transduct Target Ther. 2024;9(1):91. https:\/\/doi.org\/10.1038\/s41392-024-01797-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1300_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.133","volume":"10","author":"Y Yang","year":"2020","unstructured":"Yang Y, Liu F, Liu W, et al. Analysis of single-cell RNAseq identifies transitional states of T cells associated with hepatocellular carcinoma. Clin Transl Med. 2020;10(3):e133. https:\/\/doi.org\/10.1002\/ctm2.133.","journal-title":"Clin Transl Med"},{"issue":"6","key":"1300_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/cas.13237","volume":"108","author":"S Tsutsumi","year":"2017","unstructured":"Tsutsumi S, Saeki H, Nakashima Y, et al. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma. Cancer Sci. 2017;108(6):1119\u201327. https:\/\/doi.org\/10.1111\/cas.13237.","journal-title":"Cancer Sci"},{"key":"1300_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588552","volume":"11","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Zhang H, Chen B, et al. PD-l1-mediated immunosuppression in glioblastoma is associated with the infiltration and M2-polarization of tumor-associated macrophages. Front Immunol. 2020;11:588552. https:\/\/doi.org\/10.3389\/fimmu.2020.588552.","journal-title":"Front Immunol"},{"issue":"2","key":"1300_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.htct.2023.05.002","volume":"46","author":"LR Sampaio","year":"2024","unstructured":"Sampaio LR, Viana MA, de Oliveira VS, et al. High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms. Hematol Transfus Cell Ther. 2024;46(2):146\u201352. https:\/\/doi.org\/10.1016\/j.htct.2023.05.002.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"1\u20132","key":"1300_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jin P, Wang X. N(6)-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A\/PD-L1 manner. Apoptosis. 2024;29(1\u20132):142\u201353. https:\/\/doi.org\/10.1007\/s10495-023-01885-7.","journal-title":"Apoptosis"},{"issue":"11","key":"1300_CR25","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1038\/leu.2017.105","volume":"31","author":"VN Thiel","year":"2017","unstructured":"Thiel VN, Giaimo BD, Schwarz P, et al. Heterodimerization of AML1\u2013ETO with CBF\u03b2 is required for leukemogenesis but not for myeloproliferation. Leukemia. 2017;31(11):2491\u2013502. https:\/\/doi.org\/10.1038\/leu.2017.105.","journal-title":"Leukemia"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01300-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:03:00Z","timestamp":1759266180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01300-0","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"168"}}